Imperial College London and King's College London hope to profit from partnerships with venture capitalists. Imperial plans to raise £50 million to invest in spin-off companies from its partnership with specialist biosciences fund manager, BioScience Managers Ltd. King's has signed a £5 million agreement with IP2IPO, a subsidiary of an investment bank. IP2IPO will invest in the college's spin-off companies over the next five years, in return for a 20 per cent share of the college's interest in them.
请先注册再继续
为何要注册?
- 注册是免费的,而且十分便捷
- 注册成功后,您每月可免费阅读3篇文章
- 订阅我们的邮件
已经注册或者是已订阅?
Please or to read this article.